Inhibition of glucose metabolism abrogates the effector phase of bullous pemphigoid-like epidermolysis bullosa acquisita

Author(s):  
Paul Schilf ◽  
Marie Schmitz ◽  
Aleksandra Derenda-Hell ◽  
Markus Thieme ◽  
Tabea Bremer ◽  
...  
2015 ◽  
Vol 237 (1) ◽  
pp. 111-122 ◽  
Author(s):  
Hengameh Sadeghi ◽  
Yask Gupta ◽  
Steffen Möller ◽  
Unni K Samavedam ◽  
Martina Behnen ◽  
...  

Dermatology ◽  
1999 ◽  
Vol 198 (3) ◽  
pp. 310-313 ◽  
Author(s):  
N. Wieme ◽  
J. Lambert ◽  
M. Moerman ◽  
M.L. Geerts ◽  
L. Temmerman ◽  
...  

2018 ◽  
Vol 19 (2) ◽  
pp. 123-125
Author(s):  
Sk Jakaria Been Sayeed ◽  
Md Mujibur Rahman ◽  
AKM Humayon Kabir ◽  
Md Moniruzzaman ◽  
Uzzal Mallik ◽  
...  

Bullous systemic lupus erythematosus (BSLE) is extremely rare but distinct disease, characterized by vesicobullous skin eruptions in systemic lupus erythematosus (SLE). It can develop either before or after a diagnosis of SLE has been established. BSLE is characterized by a dermatitis herpetiformis-like histology and an autoimmunity to type VII collagen. It must be differentiated from other autoimmune vesicobullous diseases such as epidermolysis bullosa acquisita, dermatitis herpetiformis, linear IgA disease, and bullous pemphigoid. Its important to combine clinical, histological, and immunofluorescence findings to establish a diagnosis of BSLE. We report a case of BSLE to illustrate and emphasize the need for an integrative diagnostic approach.J MEDICINE JUL 2018; 19 (2) : 123-125


1996 ◽  
Vol 135 (3) ◽  
pp. 443-447 ◽  
Author(s):  
Y. KAWACHI ◽  
M. IKEGAMI ◽  
T. HASHIMOTO ◽  
K. MATSUMURA ◽  
T. TANAKA ◽  
...  

2009 ◽  
Vol 15 (3) ◽  
pp. 184-190 ◽  
Author(s):  
S. Edwards ◽  
S. H. Wakelin ◽  
F. Wojnarowska ◽  
R. A. Marsden ◽  
G. Kirtschig ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document